46 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
29 Jul 21
Oncorus Expands its Board with Appointment of Barbara Yanni
4:31pm
and contributions as we build for long-term growth and success.”
Oncorus is advancing a portfolio of iTu- and IV-administered viral immunotherapies for multiple … candidates’ therapeutic potential and clinical benefits, mechanism of action and utility; long-term growth strategies; and expectations regarding
8-K
EX-99.1
ONCR
Oncorus, Inc.
22 May 23
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
4:13pm
Investments
Working capital (1)
Property and equipment, net
Right-of-use asset
Total assets
Debt, net of debt discount and issuance fees
Long term lease
8-K
EX-99.1
ONCR
Oncorus, Inc.
4 May 21
Oncorus Reports First Quarter 2021 Financial Results and Provides Business Highlights
7:15am
asset
Total assets
Long term lease liability
Total liabilities
Total stockholders’ equity
Working capital is defined as current assets less current liabilities
8-K
EX-99.1
ONCR
Oncorus, Inc.
5 Apr 22
Entry into a Material Definitive Agreement
7:10am
on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries
8-K
EX-99.1
eog2 f7pc5miugi
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
8-K
EX-99.1
rxsnckkhfwfzp 7w4
2 Nov 22
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:11am
8-K
EX-99.1
2xxn64xu
3 Nov 21
Oncorus Reports Third Quarter 2021 Financial Results and Provides Business Updates
7:18am
8-K
EX-99.1
z9dphkh86dv5
4 May 22
Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates
7:15am
8-K
EX-99.1
fremn
9 Mar 22
Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:46am
8-K
EX-99.1
lfw6lkfs1g1s8nho1rmx
4 Aug 21
Oncorus Reports Second Quarter 2021 Financial Results and Provides Business Highlights
7:09am
8-K
EX-99.1
ycfybllr1lks29
10 Mar 21
Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
7:15am
10-K
3p48y
10 Mar 21
Annual report
4:12pm
PRE 14A
uwvq1qp02ei1vr4b mgj
12 Jun 23
Preliminary proxy
6:33am
S-1/A
59lik6v
28 Sep 20
IPO registration (amended)
6:20am
DRS/A
2xwvlwr
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
t5091ew
26 Aug 20
Draft registration statement (amended)
12:00am